Why the study?
Does ECV measurement by CMR improve the detection of cardiac involvement compared to conventional LGE imaging in muscular dystrophy patients?
Does ECV measurement by CMR improve the detection of cardiac involvement compared to conventional LGE imaging in muscular dystrophy patients?
ECV measurement by CMR provides a potential quantitative tool for detecting subtle diffuse myocardial fibrosis in muscular dystrophy patients, offering additional diagnostic value over conventional LGE imaging.
Answers are grounded in this paper and cite their sources.
May enhance diffuse fibrosis detection beyond LGE in muscular dystrophy; leaves open impact on management or outcomes.
ECV measurement by CMR is a useful tool in assessing the total extent of myocardial fibrosis as well as in depicting subtle diffuse fibrosis in areas of normal appearing myocardium on LGE-images. Thus, myocardial ECV is a potential additional quantitative tool for accurate detection of cardiac involvement and risk stratification in muscular dystrophy patients.
No takes yet. Share an insight, caveat, or question.
Florian et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: